Oxaliplatin

Product NDC
31722-358
11-digit product format
317220358
Labeler code
31722
Product ID
31722-358_3fee20f4-5fee-8b4e-e063-6294a90a1a0a
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Oxaliplatin
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Labeler
Camber Pharmaceuticals, Inc.
Application
ANDA217925
Marketing category
ANDA
Marketing start
2025-01-27
Substance
OXALIPLATIN
Active strength
100 mg/20mL
Pharmacologic classes
Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A217925-001OXALIPLATINOXALIPLATIN50MG/10ML (5MG/ML)INJECTABLE / INTRAVENOUSAP2025-01-27
A217925-002OXALIPLATINOXALIPLATIN100MG/20ML (5MG/ML)INJECTABLE / INTRAVENOUSAP2025-01-27

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A217925-001AP
A217925-002AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A217925-001OXALIPLATIN50MG/10ML (5MG/ML)INJECTABLE / INTRAVENOUSAP2025-01-27011fe1cb6892…
2026-02-19 14:30 UTC2026-02A217925-002OXALIPLATIN100MG/20ML (5MG/ML)INJECTABLE / INTRAVENOUSAP2025-01-27011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217925-001OXALIPLATIN50MG/10ML (5MG/ML)INJECTABLE / INTRAVENOUSAP2025-01-2731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217925-002OXALIPLATIN100MG/20ML (5MG/ML)INJECTABLE / INTRAVENOUSAP2025-01-2731067a03dcf5…
2025-08-23 18:47 UTC2025-08A217925-001OXALIPLATIN50MG/10ML (5MG/ML)INJECTABLE / INTRAVENOUSAP2025-01-276a471c1ec25d…
2025-08-23 18:47 UTC2025-08A217925-002OXALIPLATIN100MG/20ML (5MG/ML)INJECTABLE / INTRAVENOUSAP2025-01-276a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A217925-001OXALIPLATIN50MG/10ML (5MG/ML)INJECTABLE / INTRAVENOUSAP2025-01-27fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A217925-002OXALIPLATIN100MG/20ML (5MG/ML)INJECTABLE / INTRAVENOUSAP2025-01-27fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A217925-001OXALIPLATIN50MG/10ML (5MG/ML)INJECTABLE / INTRAVENOUSAP2025-01-27b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A217925-002OXALIPLATIN100MG/20ML (5MG/ML)INJECTABLE / INTRAVENOUSAP2025-01-27b8a1b40f171c…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A217925-001OXALIPLATIN50MG/10ML (5MG/ML)INJECTABLE / INTRAVENOUSAP2025-01-27a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A217925-002OXALIPLATIN100MG/20ML (5MG/ML)INJECTABLE / INTRAVENOUSAP2025-01-27a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A217925-001AP1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A217925-002AP1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217925-001AP131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217925-002AP131067a03dcf5…
2025-08-23 18:47 UTC2025-08A217925-001AP16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A217925-002AP16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A217925-001AP1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A217925-002AP1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A217925-001AP1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A217925-002AP1b8a1b40f171c…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A217925-001AP1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A217925-002AP1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
Oxaliplatin
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
OXALIPLATIN100 mg/20mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
04ZR38536JInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1736776Internal RxNorm lookup
1736781Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
b0799e39-7b1e-430a-b159-062b39521001Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
0364c41f-a4ea-b691-2739-986f76e794e5Product name920190125
b153e9b5-916b-4df6-8413-d22b82f1d312Product name220170720

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
31722-358-20Oxaliplatin1 in 1 CARTONINJECTION, SOLUTION, CONCENTRATE11
31722-358-20Oxaliplatin20 mL in 1 VIAL, SINGLE-DOSEINJECTION, SOLUTION, CONCENTRATE201

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OxaliplatinOXALIPLATINCamber Pharmaceuticals, Inc.b0799e39-7b1e-430a-b159-062b395210012025-09-29Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 217925
application number: ANDA217925
ndc (product): 31722-358

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1736781oxaliplatin 100 MG in 20 ML InjectionPSNb0799e39-7b1e-430a-b159-062b395210011
1736776oxaliplatin 50 MG in 10 ML InjectionPSNb0799e39-7b1e-430a-b159-062b395210011
173677610 ML oxaliplatin 5 MG/ML InjectionSCDb0799e39-7b1e-430a-b159-062b395210011
173678120 ML oxaliplatin 5 MG/ML InjectionSCDb0799e39-7b1e-430a-b159-062b395210011
1736781oxaliplatin 100 MG per 20 ML InjectionSYb0799e39-7b1e-430a-b159-062b395210011
1736776oxaliplatin 50 MG per 10 ML InjectionSYb0799e39-7b1e-430a-b159-062b395210011

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
31722-358-20317220358201 VIAL, SINGLE-DOSE in 1 CARTON (31722-358-20) / 20 mL in 1 VIAL, SINGLE-DOSE2025-01-27NoNoCurrent